Variant report

Variant	nsv890947
Chromosome Location	chr8:61815886-61882751
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1864)
CpG islands
(count:1771)
Chromatin interactive
region (count:28)
LncRNA
region (count:42)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1864 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr8:61862377-61862637	HepG2	liver:	n/a	n/a
2	ARID3A	chr8:61821701-61821894	K562	blood:	n/a	n/a
3	ATF1	chr8:61824325-61824568	K562	blood:	n/a	n/a
4	ATF1	chr8:61838911-61839111	K562	blood:	n/a	n/a
5	ATF1	chr8:61863520-61863934	K562	blood:	n/a	n/a
6	ATF2	chr8:61859097-61859551	GM12878	blood:	n/a	n/a
7	ATF2	chr8:61838738-61839676	GM12878	blood:	n/a	n/a
8	ATF2	chr8:61870409-61870886	GM12878	blood:	n/a	n/a
9	ATF2	chr8:61828744-61829645	GM12878	blood:	n/a	n/a
10	ATF2	chr8:61841401-61842479	GM12878	blood:	n/a	n/a
11	ATF2	chr8:61821261-61822386	GM12878	blood:	n/a	n/a
12	ATF2	chr8:61823937-61825624	GM12878	blood:	n/a	n/a
13	ATF2	chr8:61822388-61822829	GM12878	blood:	n/a	n/a
14	ATF2	chr8:61859704-61860235	GM12878	blood:	n/a	n/a
15	ATF2	chr8:61823841-61825430	GM12878	blood:	n/a	n/a
16	ATF2	chr8:61863396-61863968	GM12878	blood:	n/a	n/a
17	ATF2	chr8:61828593-61829680	GM12878	blood:	n/a	n/a
18	ATF2	chr8:61838723-61840020	GM12878	blood:	n/a	n/a
19	ATF2	chr8:61863437-61864041	GM12878	blood:	n/a	n/a
20	ATF2	chr8:61841465-61842418	GM12878	blood:	n/a	n/a
21	ATF2	chr8:61821916-61822700	GM12878	blood:	n/a	n/a
22	ATF2	chr8:61838273-61838710	GM12878	blood:	n/a	n/a
23	ATF2	chr8:61859562-61860359	GM12878	blood:	n/a	n/a
24	ATF2	chr8:61815744-61817395	GM12878	blood:	n/a	n/a
25	ATF2	chr8:61815624-61817391	GM12878	blood:	n/a	n/a
26	BACH1	chr8:61822386-61822580	H1-hESC	embryonic stem cell:	n/a	n/a
27	BACH1	chr8:61834885-61835038	H1-hESC	embryonic stem cell:	n/a	n/a
28	BACH1	chr8:61824664-61824827	H1-hESC	embryonic stem cell:	n/a	n/a
29	BACH1	chr8:61835323-61835552	H1-hESC	embryonic stem cell:	n/a	n/a
30	BACH1	chr8:61834052-61834461	H1-hESC	embryonic stem cell:	n/a	n/a
31	BATF	chr8:61840043-61840540	GM12878	blood:	n/a	n/a
32	BATF	chr8:61846397-61846650	GM12878	blood:	n/a	chr8:61846512-61846523
33	BATF	chr8:61828990-61829615	GM12878	blood:	n/a	n/a
34	BATF	chr8:61839010-61839389	GM12878	blood:	n/a	n/a
35	BATF	chr8:61816012-61816513	GM12878	blood:	n/a	n/a
36	BATF	chr8:61824072-61824992	GM12878	blood:	n/a	n/a
37	BATF	chr8:61841631-61842120	GM12878	blood:	n/a	n/a
38	BATF	chr8:61824089-61824613	GM12878	blood:	n/a	n/a
39	BATF	chr8:61816011-61816561	GM12878	blood:	n/a	n/a
40	BATF	chr8:61816573-61817184	GM12878	blood:	n/a	chr8:61816962-61816971
41	BATF	chr8:61821916-61822683	GM12878	blood:	n/a	n/a
42	BATF	chr8:61863456-61863934	GM12878	blood:	n/a	chr8:61863664-61863675
43	BATF	chr8:61816721-61817176	GM12878	blood:	n/a	chr8:61816962-61816971
44	BATF	chr8:61838927-61839593	GM12878	blood:	n/a	n/a
45	BATF	chr8:61841547-61842275	GM12878	blood:	n/a	n/a
46	BATF	chr8:61862182-61862445	GM12878	blood:	n/a	n/a
47	BATF	chr8:61863404-61863901	GM12878	blood:	n/a	chr8:61863664-61863675
48	BATF	chr8:61850679-61850998	GM12878	blood:	n/a	n/a
49	BCL11A	chr8:61841589-61842297	GM12878	blood:	n/a	chr8:61842151-61842160
50	BCL11A	chr8:61841510-61842296	GM12878	blood:	n/a	chr8:61842151-61842160

(count:1771 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:61834534-61834584	Caco-2	colon:	n/a
2	chr8:61880392-61880442	NT2-D1	testis:	n/a
3	chr8:61834534-61834584	Caco-2	colon:	n/a
4	chr8:61880392-61880442	NT2-D1	testis:	n/a
5	chr8:61834534-61834584	HEEpiC	esophagus:	n/a
6	chr8:61823027-61823077	IMR90	lung:	fetal
7	chr8:61835708-61835758	SAEC	small airway:	n/a
8	chr8:61874021-61874071	BE2_C	brain:	n/a
9	chr8:61821400-61821450	HPAEpiC	pulmonary alveolar:	n/a
10	chr8:61863697-61863747	HCT-116	colon:	n/a
11	chr8:61833707-61833757	PrEC	prostate:	n/a
12	chr8:61835708-61835758	GM12891	blood:	n/a
13	chr8:61839426-61839476	IMR90	lung:	fetal
14	chr8:61834943-61834993	T-47D	breast:	n/a
15	chr8:61861713-61861763	SK-N-SH_RA	brain:	n/a
16	chr8:61834943-61834993	RPTEC	kidney:	n/a
17	chr8:61822740-61822790	HMEC	breast:	n/a
18	chr8:61822816-61822866	H1-hESC	embryonic stem cell:	embryo
19	chr8:61822740-61822790	SK-N-SH	brain:	n/a
20	chr8:61835848-61835898	A549	lung:	n/a
21	chr8:61839426-61839476	SK-N-MC	brain:	n/a
22	chr8:61877404-61877454	MCF10A-Er-Src	breast:	n/a
23	chr8:61831678-61831728	ProgFib	skin:	n/a
24	chr8:61834943-61834993	HCT-116	colon:	n/a
25	chr8:61835848-61835898	SAEC	small airway:	n/a
26	chr8:61834501-61834551	NHDF-neo	bronchial:	n/a
27	chr8:61821400-61821450	PFSK-1	brain:	n/a
28	chr8:61861713-61861763	HCF	heart:	n/a
29	chr8:61823027-61823077	NHDF-neo	bronchial:	n/a
30	chr8:61837048-61837098	HEEpiC	esophagus:	n/a
31	chr8:61861713-61861763	AoSMC	blood vessel:	n/a
32	chr8:61823275-61823325	NHBE	bronchial:	n/a
33	chr8:61834943-61834993	Jurkat	blood:	n/a
34	chr8:61834534-61834584	NT2-D1	testis:	n/a
35	chr8:61836533-61836583	PrEC	prostate:	n/a
36	chr8:61823275-61823325	HL-60	blood:	n/a
37	chr8:61824739-61824789	HRE	kidney:	n/a
38	chr8:61835119-61835169	IMR90	lung:	fetal
39	chr8:61823275-61823325	PFSK-1	brain:	n/a
40	chr8:61835175-61835225	MCF10A-Er-Src	breast:	n/a
41	chr8:61834501-61834551	HCF	heart:	n/a
42	chr8:61835848-61835898	T-47D	breast:	n/a
43	chr8:61818850-61818900	ECC-1	luminal epithelium:	n/a
44	chr8:61823027-61823077	HNPCEpiC	eye:	n/a
45	chr8:61834501-61834551	HepG2	liver:	n/a
46	chr8:61825469-61825519	U87	brain:	n/a
47	chr8:61823027-61823077	CMK	blood:	n/a
48	chr8:61821400-61821450	SK-N-SH	brain:	n/a
49	chr8:61822428-61822478	NT2-D1	testis:	n/a
50	chr8:61834943-61834993	AG04450	lung:	fetal

(count:28 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:61825100..61827766-chr8:61844156..61846104,2	MCF-7	breast:
2	chr8:61865655..61871190-chr8:61872116..61876156,6	K562	blood:
3	chr8:61833393..61835829-chr8:61842077..61844406,2	K562	blood:
4	chr8:61854686..61856226-chr8:61860743..61862547,2	K562	blood:
5	chr8:61812523..61815203-chr8:61818659..61820454,2	MCF-7	breast:
6	chr8:61807812..61810672-chr8:61824288..61826200,2	MCF-7	breast:
7	chr8:61814901..61816723-chr8:61822451..61825300,2	MCF-7	breast:
8	chr8:61873885..61874676-chr8:62008576..62009223,2	K562	blood:
9	chr8:61853213..61856894-chr8:61860542..61864181,3	MCF-7	breast:
10	chr8:61833393..61835829-chr8:61842077..61844406,2	K562	blood:
11	chr8:61837800..61840133-chr8:61855900..61858739,2	MCF-7	breast:
12	chr8:61851365..61853234-chr8:61857166..61859095,2	K562	blood:
13	chr8:61525760..61527520-chr8:61863383..61865720,2	K562	blood:
14	chr8:61821354..61824563-chr8:61827289..61829663,3	K562	blood:
15	chr8:61837800..61840133-chr8:61855900..61858739,2	MCF-7	breast:
16	chr8:61836839..61839407-chr8:61851968..61854630,2	MCF-7	breast:
17	chr8:61854686..61856226-chr8:61860743..61862547,2	K562	blood:
18	chr8:61865655..61871190-chr8:61872116..61876156,6	K562	blood:
19	chr8:61835952..61838593-chr8:61841536..61843319,2	K562	blood:
20	chr8:61873753..61875664-chr8:61875994..61878043,2	MCF-7	breast:
21	chr8:61849973..61853461-chr8:61859040..61861744,3	MCF-7	breast:
22	chr8:61873753..61875664-chr8:61875994..61878043,2	MCF-7	breast:
23	chr8:61821654..61824637-chr8:61859951..61861851,2	MCF-7	breast:
24	chr8:61825100..61827766-chr8:61844156..61846104,2	MCF-7	breast:
25	chr8:61853213..61856894-chr8:61860542..61864181,3	MCF-7	breast:
26	chr8:61814318..61816214-chr8:61820305..61823088,2	K562	blood:
27	chr8:61829988..61832075-chr8:61833915..61836317,2	K562	blood:
28	chr8:61835952..61838593-chr8:61841536..61843319,2	K562	blood:

(count:42 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CLVS1-1	chr8:61878729-61879015	ENSG00000254777
2	lnc-CLVS1-1	chr8:61878729-61879017	NONHSAT126853
3	lnc-CLVS1-1	chr8:61823149-61823225	NONHSAT126853
4	lnc-CLVS1-1	chr8:61838352-61838934	NONHSAT126853
5	lnc-CLVS1-1	chr8:61850156-61850643	NONHSAT126853
6	lnc-CLVS1-1	chr8:61875911-61875984	ENSG00000254777
7	lnc-CLVS1-1	chr8:61874529-61875010	NONHSAT126853
8	lnc-CLVS1-1	chr8:61877796-61877920	ENSG00000254777
9	lnc-ASPH-5	chr8:61880132-61880307	XLOC_007097
10	lnc-ASPH-5	chr8:61880132-61880323	NONHSAT126857
11	lnc-ASPH-5	chr8:61880132-61880307	NR_034003
12	lnc-CLVS1-1	chr8:61822245-61822787	NONHSAT126853
13	lnc-CLVS1-1	chr8:61878746-61878796	XLOC_006815
14	lnc-CLVS1-1	chr8:61875910-61875992	NONHSAT126853
15	lnc-CLVS1-1	chr8:61879030-61879056	NONHSAT126853
16	lnc-ASPH-5	chr8:61877666-61879016	NONHSAT126857
17	lnc-CLVS1-1	chr8:61831540-61831609	ENSG00000254777
18	lnc-CLVS1-1	chr8:61823149-61823225	ENSG00000254777
19	lnc-CLVS1-1	chr8:61873549-61874008	NONHSAT126853
20	lnc-ASPH-5	chr8:61878680-61879016	NR_034003
21	lnc-CLVS1-1	chr8:61865489-61865594	ENSG00000254777
22	lnc-CLVS1-1	chr8:61831540-61835815	NONHSAT126851
23	lnc-ASPH-5	chr8:61880132-61880334	ENSG00000254802
24	lnc-CLVS1-1	chr8:61832729-61832981	ENSG00000254777
25	lnc-CLVS1-1	chr8:61879073-61879112	NONHSAT126853
26	lnc-CLVS1-1	chr8:61877289-61877382	ENSG00000254777
27	lnc-CLVS1-1	chr8:61880132-61880307	NONHSAT126853
28	lnc-ASPH-5	chr8:61878361-61879016	ENSG00000254802
29	lnc-CLVS1-1	chr8:61832729-61832981	NONHSAT126853
30	lnc-CLVS1-1	chr8:61822612-61822787	ENSG00000254777
31	lnc-CLVS1-1	chr8:61878733-61879116	ENSG00000254777
32	lnc-ASPH-6	chr8:61823051-61823092	XLOC_007096
33	lnc-CLVS1-1	chr8:61847014-61847227	NONHSAT126853
34	lnc-CLVS1-1	chr8:61832729-61832981	ENSG00000254777
35	lnc-CLVS1-1	chr8:61831540-61831609	ENSG00000254777
36	lnc-CLVS1-1	chr8:61877795-61877920	NONHSAT126853
37	lnc-CLVS1-1	chr8:61831539-61831609	NONHSAT126853
38	lnc-CLVS1-1	chr8:61865488-61865594	NONHSAT126853
39	lnc-CLVS1-1	chr8:61877289-61877382	ENSG00000254777
40	lnc-ASPH-5	chr8:61878682-61879016	XLOC_007097
41	lnc-ASPH-6	chr8:61822077-61822321	XLOC_007096
42	lnc-CLVS1-1	chr8:61877116-61877641	NONHSAT126853

No data

Variant related genes	Relation type
ENSG00000255397	TF binding region
ENSG00000271377	TF binding region
ENSG00000254777	TF binding region
ENSG00000254802	TF binding region
ENSG00000255397	CpG island
ENSG00000271377	CpG island
ENSG00000254777	CpG island
ENSG00000254802	CpG island
ENSG00000255397	chromatin interactions
ENSG00000254777	chromatin interactions
ATP1A2	miRNA target sites

Extended variants
information (count: 2644 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:2644 , 50 per page) page: 1 2 3 4 5 6 7 ... 53

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10957167	chr8:61815886-61815887	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs558163593	chr8:61815926-61815927	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs561725975	chr8:61815962-61815963	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs527529890	chr8:61815968-61815969	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs79519526	chr8:61816012-61816013	Enhancers Active TSS Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs564382283	chr8:61816066-61816067	Enhancers Active TSS Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs185015832	chr8:61816094-61816095	Enhancers Active TSS Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs574095645	chr8:61816155-61816156	Enhancers Active TSS Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs573947441	chr8:61816183-61816184	Enhancers Active TSS Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs544421386	chr8:61816212-61816213	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs4375041	chr8:61816245-61816246	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs575331372	chr8:61816255-61816256	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs545557495	chr8:61816285-61816286	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs568408095	chr8:61816299-61816300	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs12676011	chr8:61816303-61816304	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs115710385	chr8:61816304-61816305	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs56091339	chr8:61816318-61816319	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs75163245	chr8:61816319-61816320	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs150297359	chr8:61816320-61816321	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs141038541	chr8:61816373-61816374	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs62525873	chr8:61816380-61816381	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs528062954	chr8:61816554-61816555	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs73260564	chr8:61816567-61816568	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs561986319	chr8:61816602-61816603	Enhancers Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs149420307	chr8:61816670-61816671	Enhancers Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs550829223	chr8:61816713-61816714	Enhancers Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs188234227	chr8:61816770-61816771	Enhancers Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs533517689	chr8:61816785-61816786	Enhancers Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs375197298	chr8:61816838-61816839	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs551577298	chr8:61816839-61816840	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs566914709	chr8:61816899-61816900	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs11784276	chr8:61816973-61816974	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs144681359	chr8:61816996-61816997	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs569697018	chr8:61817031-61817032	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs58610284	chr8:61817098-61817099	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs11784344	chr8:61817103-61817104	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs77301757	chr8:61817146-61817147	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs4737568	chr8:61817169-61817170	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs72652539	chr8:61817289-61817290	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs370540409	chr8:61817374-61817375	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs557572103	chr8:61817407-61817408	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs35359019	chr8:61817408-61817409	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs540250023	chr8:61817421-61817422	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs148507682	chr8:61817495-61817496	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs142893623	chr8:61817535-61817536	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs544517941	chr8:61817561-61817562	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs146087920	chr8:61817581-61817582	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs537994519	chr8:61817611-61817612	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs554631889	chr8:61817612-61817613	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs181041530	chr8:61817641-61817642	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Ewing''s sarcoma	21437220	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Seminomas	18059402	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Pancreatic cancer	21811587	CNVD
Thyroid cancer	19087340	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	17603634	CNVD
Disorders of sex development	21048976	CNVD
Testicular cancer	18059402	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
primary effusion lymphomas	17116491	CNVD
Esophageal cancer	20955586	CNVD
Multiple myeloma	16461302	CNVD
abnormal development	18461090	CNVD
Cancer	20164920	CNVD
Oral cancer	21386901	CNVD
Uveal melanoma	21693616	CNVD
Langer-Giedion syndrome	22283845	CNVD
Cancer	21637783	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	20632083	CNVD
Breast cancer	19602461	CNVD
Cancer	22429812	CNVD
Endometrial cancer	22040021	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oral cancer	19627613	CNVD
Prostate cancer	21088497	CNVD
colon cancer	17210682	CNVD
Breast cancer	21264507	CNVD
Breast cancer	22028636	CNVD
Acute myeloid leukemia	16864856	CNVD
Salivary gland tumor	18059337	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Gastric cancer	17167181	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	16461572	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
head and neck squamous cell carcinoma	18028549	CNVD
Breast cancer	17001317	CNVD
Ewing''s sarcoma	17952124	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	16608533	CNVD
Metanephric adenoma	20802469	CNVD
Hepatocellular carcinoma	18803288	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	18628472	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	16573809	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	22183965	CNVD
Cancer	21949371	CNVD
Non-small cell lung cancer	21829676	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Acute myeloid leukemia	21358987	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Adenocarcinoma	21044232	CNVD
Squamous cell cancer	20885788	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Colorectal cancer	21645411	CNVD
Charge syndrome	20571795	CNVD
Breast cancer	22522925	CNVD
early-passage human iPS cells	21368824	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:2241 , 50 per page) page: 1 2 3 4 5 6 7 ... 45

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:61811800-61817000	Enhancers	Fetal Thymus	thymus
2	chr8:61812000-61817200	Enhancers	Primary T helper cells fromperipheralblood	blood
3	chr8:61812000-61817600	Enhancers	Primary T cells from cord blood	blood
4	chr8:61812200-61821200	Weak transcription	Right Atrium	heart
5	chr8:61813000-61816000	Weak transcription	Primary B cells from cord blood	blood
6	chr8:61813000-61816000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr8:61813800-61817200	Enhancers	Primary T helper naive cells fromperipheralblood	blood
8	chr8:61814200-61816000	Enhancers	HUVEC	blood vessel
9	chr8:61814200-61816200	Enhancers	Stomach Mucosa	stomach
10	chr8:61814200-61817400	Enhancers	Primary T killer memory cells from peripheral blood	blood
11	chr8:61814400-61816200	Enhancers	Primary neutrophils fromperipheralblood	blood
12	chr8:61814400-61816400	Enhancers	Fetal Intestine Large	intestine
13	chr8:61814600-61816200	Enhancers	HepG2	liver
14	chr8:61814600-61817400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr8:61814800-61816200	Enhancers	Fetal Intestine Small	intestine
16	chr8:61814800-61816600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
17	chr8:61814800-61817200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
18	chr8:61814800-61817400	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
19	chr8:61815000-61816800	Enhancers	Sigmoid Colon	Sigmoid Colon
20	chr8:61815000-61817000	Enhancers	Primary T cells fromperipheralblood	blood
21	chr8:61815000-61817200	Enhancers	Primary T helper naive cells from peripheral blood	blood
22	chr8:61815200-61816800	Enhancers	Small Intestine	intestine
23	chr8:61815200-61817200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
24	chr8:61815200-61817200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
25	chr8:61815400-61816000	Enhancers	Duodenum Mucosa	Duodenum
26	chr8:61815400-61817200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
27	chr8:61815600-61816000	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
28	chr8:61815600-61816200	Enhancers	Primary hematopoietic stem cells short term culture	blood
29	chr8:61815600-61816200	Active TSS	Colonic Mucosa	Colon
30	chr8:61815600-61816400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
31	chr8:61815600-61817000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
32	chr8:61815600-61817000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
33	chr8:61815600-61817200	Enhancers	Primary B cells from peripheral blood	blood
34	chr8:61815600-61817200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
35	chr8:61815600-61817400	Flanking Active TSS	GM12878-XiMat	blood
36	chr8:61815600-61818000	Weak transcription	Fetal Muscle Leg	muscle
37	chr8:61815800-61816000	Enhancers	Rectal Mucosa Donor 31	rectum
38	chr8:61815800-61816200	Active TSS	Rectal Mucosa Donor 29	rectum
39	chr8:61815800-61816600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
40	chr8:61815800-61817000	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
41	chr8:61815800-61817200	Enhancers	K562	blood
42	chr8:61816000-61816200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
43	chr8:61816000-61816400	Enhancers	Primary hematopoietic stem cells	blood
44	chr8:61816000-61816400	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
45	chr8:61816000-61816600	Enhancers	Primary B cells from cord blood	blood
46	chr8:61816000-61816600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
47	chr8:61816000-61816800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
48	chr8:61816000-61816800	Active TSS	Rectal Smooth Muscle	rectum
49	chr8:61816000-61817000	Enhancers	Primary T regulatory cells fromperipheralblood	blood
50	chr8:61816000-61817000	Flanking Active TSS	Rectal Mucosa Donor 31	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links